BDBM61816 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-indol-3-yl]-N-(5-cyclopropyl-1,3,4-thiadiazol-2-yl)acetamide::2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]-N-(5-cyclopropyl-1,3,4-thiadiazol-2-yl)acetamide::2-[1-(4-chlorophenyl)carbonyl-5-methoxy-2-methyl-indol-3-yl]-N-(5-cyclopropyl-1,3,4-thiadiazol-2-yl)ethanamide::2-[1-[(4-chlorophenyl)-oxomethyl]-5-methoxy-2-methyl-3-indolyl]-N-(5-cyclopropyl-1,3,4-thiadiazol-2-yl)acetamide::MLS000416453::SMR000264281::cid_2089534

SMILES O=C(c1cnc2c(c1)OCCN2c1ccn2c(=O)n(Cc3ccccc3)nc2c1)N1CCCCC1

InChI Key InChIKey=KAJHWQKDCIGGMD-UHFFFAOYSA-N

Data  3 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 61816   

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 61816BDBM61816(US12577217, Example 1-31)
Affinity DataIC50: 10nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2026
Entry Details
US Patent